- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 309-323 of
514 results
2120 Exhibit: About this capture information for the pdf located at httpswebarchiveo...
Document
IPR2017-01621, No. 2120-342 Exhibit - About this capture information for the pdf located at httpswebarchiveorgweb20040718112852httpwwwnebu tecde80PDFGA B depdf (P.T.A.B. Jul. 11, 20...
|
|
Cite Document
2025 Exhibit: Exhibit 2025
Document
IPR2017-01621, No. 2025-206 Exhibit - Exhibit 2025 (P.T.A.B. Oct. 13, 2017)
|
|
Cite Document
1023 Exhibit: European Patent Application Publication No EP 0372777 A2 Purewal...
Document
IPR2017-01621, No. 1023-19 Exhibit - European Patent Application Publication No EP 0372777 A2 Purewal EP 777 (P.T.A.B. Jun. 21, 2017)
|
|
Cite Document
1090 Exhibit: FDA Drug Details Website, Letairis, httpswwwaccessdatafdagovscript...
Document
IPR2017-01621, No. 1090-83 Exhibit - FDA Drug Details Website, Letairis, httpswwwaccessdatafdagovscriptscderdafindexcfmeventBasicSearchprocess accessed 5172017 (P.T.A.B. Jun. 21, 20...
|
|
Cite Document
1074 Exhibit: Adcirca, FDA Label, 52017
Document
IPR2017-01621, No. 1074-67 Exhibit - Adcirca, FDA Label, 52017 (P.T.A.B. Jun. 21, 2017)
|
|
Cite Document
1076 Exhibit: Bayer, Annual Report, 2014
Document
IPR2017-01621, No. 1076-69 Exhibit - Bayer, Annual Report, 2014 (P.T.A.B. Jun. 21, 2017)
|
|
Cite Document
1070 Exhibit: Ex 1070 Actelion Annual Report 2013 Part2
Document
IPR2017-01621, No. 1070-166 Exhibit - Ex 1070 Actelion Annual Report 2013 Part2 (P.T.A.B. Jun. 21, 2017)
|
|
Cite Document
1145 Exhibit: UTC, Form 10 K, 2003
Document
IPR2017-01621, No. 1145-137 Exhibit - UTC, Form 10 K, 2003 (P.T.A.B. Jun. 21, 2017)
|
|
Cite Document
1035 Exhibit: US Food and Drug Administration, Drug Approval Package Remodulin...
Document
IPR2017-01621, No. 1035-31 Exhibit - US Food and Drug Administration, Drug Approval Package Remodulin® approved on May 21, 2002, httpwwwaccessdatafdagovdrugsatfda docsnda200221...
|
|
Cite Document
2084 Exhibit: ClinicalTrialsgov entry for TRIUMPH trial, NCT00147199 accessed Ap...
Document
IPR2017-01621, No. 2084-294 Exhibit - ClinicalTrialsgov entry for TRIUMPH trial, NCT00147199 accessed April 20, 2018 (P.T.A.B. Apr. 27, 2018)
|
|
Cite Document
1168 Exhibit: Ex 1168 Reply in 12591,200 Jan 16, 2013
Document
IPR2017-01621, No. 1168-217 Exhibit - Ex 1168 Reply in 12591,200 Jan 16, 2013 (P.T.A.B. Feb. 9, 2018)
|
|
Cite Document
1107 Exhibit: Corrected Ex 1107 Gilead, Form 10 K, 2012
Document
IPR2017-01621, No. 1107-181 Exhibit - Corrected Ex 1107 Gilead, Form 10 K, 2012 (P.T.A.B. Jul. 19, 2017)
|
|
Cite Document
1024 Exhibit: US Patent No 4,895,719 Radhakrishnan 719
Document
IPR2017-01621, No. 1024-20 Exhibit - US Patent No 4,895,719 Radhakrishnan 719 (P.T.A.B. Jun. 21, 2017)
|
|
Cite Document
1106 Exhibit: Gilead, Form 10 K, 2011
Document
IPR2017-01621, No. 1106-99 Exhibit - Gilead, Form 10 K, 2011 (P.T.A.B. Jun. 21, 2017)
|
|
Cite Document
1003 Exhibit: Robert Voswinckel, et al Inhaled treprostinil sodium for the treatment ...
Document
IPR2017-01621, No. 1003-2 Exhibit - Robert Voswinckel, et al Inhaled treprostinil sodium for the treatment of pulmonary hypertension Abstract , Circulation, 110, 17, Supplement Oct 2004 III 295...
|
|
Cite Document
